MetLife Investment Product — Benefit payments decreased by 9.4% to -12800000000.0% in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 12.3%, from -11400000000.0% to -12800000000.0%. Over 4 years (FY 2021 to FY 2025), Investment Product — Benefit payments shows relatively stable performance with a -2.0% CAGR.
Stable or predictable payments are expected; unexpected spikes may indicate adverse mortality or lapse trends.
This represents the cash outflows made to policyholders or beneficiaries upon the occurrence of insured events or schedu...
Standard operational metric for all insurance companies.
met_segment_investment_product_benefit_payments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -12,500,000,000% | -12,500,000,000% | -12,500,000,000% | -12,400,000,000% | -10,600,000,000% | -9,900,000,000% | -10,200,000,000% | -12,000,000,000% | -12,200,000,000% | -10,800,000,000% | -11,400,000,000% | -12,900,000,000% | -13,000,000,000% | -11,800,000,000% | -11,400,000,000% | -11,400,000,000% | -11,400,000,000% | -11,600,000,000% | -11,700,000,000% | -12,800,000,000% |
| QoQ Change | — | +0.0% | +0.0% | +0.8% | +14.5% | +6.6% | -3.0% | -17.6% | -1.7% | +11.5% | -5.6% | -13.2% | -0.8% | +9.2% | +3.4% | +0.0% | +0.0% | -1.8% | -0.9% | -9.4% |
| YoY Change | — | — | — | — | +15.2% | +20.8% | +18.4% | +3.2% | -15.1% | -9.1% | -11.8% | -7.5% | -6.6% | -9.3% | +0.0% | +11.6% | +12.3% | +1.7% | -2.6% | -12.3% |